In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 19-0935V

UNPUBLISHED

JUDSON COSTLOW,

 Petitioner,

v.

SECRETARY OF HEALTH AND 

HUMAN SERVICES,

 Respondent.

Chief Special Master Corcoran 

Filed: October 30, 2020

Special Processing Unit (SPU);

Ruling on Entitlement; Concession;

Table Injury; Influenza (Flu) Vaccine;

Guillain-Barre Syndrome (GBS)

Amy A. Senerth, Muller Brazil, LLP, Dresher, PA, for petitioner.

Ronalda Elnetta Kosh, U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ENTITLEMENT1

On June 27, 2019, Judson Costlow filed a petition for compensation under the 

National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.

2

(the 

“Vaccine Act”). Petitioner alleges that he suffered Guillain-Barré syndrome (“GBS”) 

caused in fact by the influenza vaccine he received on September 16, 2016. Petition at

1, ¶¶ 2, 20. Petitioner further alleges that he received the vaccination in the United States, 

that he suffered the residual effects of his GBS for more than six months, and that neither 

Petitioner nor any other party has filed a civil action or received compensation for his 

GBS, alleged as vaccine caused. Id. at ¶¶ 2, 20-22. The case was assigned to the Special 

Processing Unit of the Office of Special Masters.

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required 

to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act 

of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government 

Services). This means the ruling will be available to anyone with access to the internet. In accordance 

with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, 

the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that 

the identified material fits within this definition, I will redact such material from public access. 

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease 

of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa 

(2012).
2

On October 30, 2020, Respondent filed his Rule 4(c) report in which he concedes

that Petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at

1. Although Respondent originally opposed compensation in this case based on his belief 

that Petitioner had failed to establish that he suffered the residual effect of his GBS for 

more than six months, upon reviewing the additional evidence provided by Petitioner he

now “has determined that [P]etitioner has satisfied this statutory requirement.” Id. at 2; 

see Section 16(c)(1)(D)(i) (statutory six-month requirement). Respondent further agrees 

that “[P]etitioner has satisfied all legal requirements for compensation under the Vaccine 

Act as set forth in the Table and the Qualification and Aids to Interpretation.” Id.

In view of Respondent’s position and the evidence of record, I find that 

Petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Brian H. Corcoran

Brian H. Corcoran

Chief Special Master